Healthcare has a supply chain problem with a longer half-life than almost any other sector. A hospital runs electronic health records, imaging systems, and infusion pumps that were designed years ago and will stay in service for years more, each carrying open-source and third-party components that keep aging while the clinical need for uptime makes patching hard. Payers and health-tech firms sit on top of the same open-source ecosystem as every other software company, but with protected health information and patient safety riding on it. The disruption caused by third-party incidents in recent years made the concentration risk impossible to ignore. In 2026, regulators are closing the gap.
The regulatory drivers
The most concrete requirement lands on device makers. Section 524B of the Federal Food, Drug, and Cosmetic Act, added by the Consolidated Appropriations Act of 2023, requires manufacturers of "cyber devices" to submit a software bill of materials with premarket submissions and to maintain a plan for monitoring and addressing postmarket vulnerabilities. The FDA's finalized premarket cybersecurity guidance operationalizes this, so an SBOM is now a gating artifact for market access, not an optional extra. Hospitals, in turn, increasingly demand those SBOMs from suppliers so they can track exposure across their fleet.
On the provider and payer side, HIPAA remains the backbone. The HHS Office for Civil Rights published a notice of proposed rulemaking in early 2025 to strengthen the HIPAA Security Rule, and the proposal would make several controls explicit that many organizations treat as optional today, including a technology asset inventory, a network map, mandatory encryption, multi-factor authentication, and regular vulnerability scanning. Even before finalization, it signals where enforcement expectations are heading: you cannot protect, or prove you protect, an environment you have not inventoried. Alongside it, HHS's voluntary Cybersecurity Performance Goals give the sector a baseline, and in the EU the NIS2 Directive designates healthcare as an essential sector with binding risk-management and incident-reporting duties.
What a healthcare program needs
A healthcare supply chain program has to serve two audiences at once: patient safety and data protection. That shapes its priorities.
It needs a living inventory that spans both the software your teams build and the third-party and medical-device software you operate, because the strengthened HIPAA expectations and the FDA's postmarket monitoring both start from "what do we have." It needs the ability to ingest supplier and device SBOMs and reconcile them against current vulnerability data, so that when a component is found vulnerable you can immediately tell which systems and devices are affected. It needs prioritization tuned to real exposure, because clinical environments cannot absorb constant emergency patching, and effort has to go where risk is genuine. And it needs remediation and evidence workflows that survive an OCR investigation or an FDA postmarket review.
Practical controls
Require an SBOM from every software supplier and medical-device manufacturer, and store those SBOMs where you can query them the moment a new vulnerability is disclosed. For software you build, generate a signed SBOM on every build and enforce it as a release artifact. Segment clinical networks so a compromised component cannot move laterally into patient-care systems, and treat internet-facing appliances as assume-breach.
Put policy gates in your build pipeline that block releases containing known-exploited or malicious components, and route vulnerability findings through reachability analysis so clinicians and engineers are not pulled into emergency changes for flaws that are not actually reachable. Maintain an incident playbook that explicitly covers a third-party or upstream compromise, since the highest-impact healthcare incidents of recent years originated with vendors rather than inside the hospital.
How Safeguard helps
Safeguard turns these requirements into an operating routine. Our software composition analysis inventories every direct and transitive dependency and applies reachability analysis, so the flood of raw CVEs becomes the shortlist of vulnerabilities whose code your systems actually execute. That focus is decisive in an environment where change windows are scarce and any patch to a clinical system carries risk.
SBOM Studio generates and version-controls SBOMs for the software you build and ingests SBOMs and AIBOMs from your suppliers and device makers, giving you the cross-fleet inventory the FDA postmarket model and the strengthened HIPAA expectations both assume. When a fix is warranted, Griffin AI generates and validates the remediation and opens it as a reviewable pull request, so your engineers spend time approving fixes rather than researching them.
For HIPAA, HHS CPG, and NIS2 reporting, the compliance module maps findings and controls to the relevant frameworks and exports audit-ready evidence, so demonstrating diligence to OCR or a European regulator is a download rather than a scramble. And because patient data carries strict residency and confidentiality obligations, Safeguard deploys as SaaS, self-hosted, or fully air-gapped, keeping protected health information and source code inside your own boundary.
Healthcare cannot trade patient safety for velocity, and it no longer has to trade visibility for either. See how the pieces map to your environment on the solutions overview, or start a free trial.
Frequently Asked Questions
Do we have to provide an SBOM to sell a medical device now? For devices that meet the FDA's definition of a cyber device, yes. Section 524B requires an SBOM as part of the premarket submission along with a plan to monitor and remediate postmarket vulnerabilities, and the FDA's finalized guidance treats these as expected content. In practice, hospitals are also requesting SBOMs from suppliers regardless of the device class so they can manage fleet-wide exposure.
How do we handle vulnerabilities in devices we cannot easily patch? Reachability and exposure context are what make this manageable. When you can ingest a device SBOM and see which vulnerabilities are actually reachable and internet-exposed, you can prioritize compensating controls such as segmentation and monitoring for the ones that matter, rather than attempting risky patches across an entire fleet at once.
Is the strengthened HIPAA Security Rule in effect? The HHS OCR proposal to strengthen the Security Rule was published as a notice of proposed rulemaking and would make controls like an asset inventory, network map, encryption, and MFA explicit. Organizations should track its progress, but the direction is already clear enough that building an accurate technology inventory now is the prudent move.
Can Safeguard run without cloud access to our PHI environment? Yes. Safeguard supports self-hosted and fully air-gapped deployment, so source code, SBOMs, and findings can remain entirely within your controlled environment, which helps satisfy residency and confidentiality obligations tied to protected health information.
Explore Safeguard's software composition analysis, SBOM Studio, Griffin AI, and compliance evidence, or read the documentation to get started.